Standard
Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus. / Aaboe, K; Knop, F K; Vilsbøll, T; Deacon, C F; Holst, Jens Juul; Madsbad, S; Krarup, Troels Magelund.
In:
Diabetes, Obesity and Metabolism, Vol. 12, No. 4, 01.04.2010, p. 323-33.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Aaboe, K
, Knop, FK, Vilsbøll, T
, Deacon, CF, Holst, JJ, Madsbad, S & Krarup, TM 2010, '
Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus',
Diabetes, Obesity and Metabolism, vol. 12, no. 4, pp. 323-33.
https://doi.org/10.1111/j.1463-1326.2009.01167.xAPA
Aaboe, K.
, Knop, F. K., Vilsbøll, T.
, Deacon, C. F., Holst, J. J., Madsbad, S., & Krarup, T. M. (2010).
Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus.
Diabetes, Obesity and Metabolism,
12(4), 323-33.
https://doi.org/10.1111/j.1463-1326.2009.01167.xVancouver
Aaboe K
, Knop FK, Vilsbøll T
, Deacon CF, Holst JJ, Madsbad S et al.
Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus.
Diabetes, Obesity and Metabolism. 2010 Apr 1;12(4):323-33.
https://doi.org/10.1111/j.1463-1326.2009.01167.xAuthor
Aaboe, K ; Knop, F K ; Vilsbøll, T ; Deacon, C F ; Holst, Jens Juul ; Madsbad, S ; Krarup, Troels Magelund. / Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus. In: Diabetes, Obesity and Metabolism. 2010 ; Vol. 12, No. 4. pp. 323-33.
Bibtex
@article{236421d49c5c444c96f5947d5039b8a4,
title = "Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus",
abstract = "To examine the effects of 12 weeks of treatment with the DPP-4 inhibitor, sitagliptin, on gastrointestinal hormone responses to a standardized mixed meal and beta cell secretory capacity, measured as glucose and non-glucose induced insulin secretion during a hyperglycaemic clamp, in patients with type 2 diabetes.",
keywords = "Adult, Aged, Diabetes Mellitus, Type 2, Dipeptidyl-Peptidase IV Inhibitors, Double-Blind Method, Drug Administration Schedule, Female, Gastric Inhibitory Polypeptide, Glucagon-Like Peptide 1, Glucagon-Like Peptide 2, Humans, Hypoglycemic Agents, Insulin, Male, Metformin, Middle Aged, Peptide YY, Postprandial Period, Pyrazines, Triazoles",
author = "K Aaboe and Knop, {F K} and T Vilsb{\o}ll and Deacon, {C F} and Holst, {Jens Juul} and S Madsbad and Krarup, {Troels Magelund}",
year = "2010",
month = apr,
day = "1",
doi = "10.1111/j.1463-1326.2009.01167.x",
language = "English",
volume = "12",
pages = "323--33",
journal = "Diabetes, Obesity and Metabolism",
issn = "1462-8902",
publisher = "Wiley-Blackwell",
number = "4",
}
RIS
TY - JOUR
T1 - Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus
AU - Aaboe, K
AU - Knop, F K
AU - Vilsbøll, T
AU - Deacon, C F
AU - Holst, Jens Juul
AU - Madsbad, S
AU - Krarup, Troels Magelund
PY - 2010/4/1
Y1 - 2010/4/1
N2 - To examine the effects of 12 weeks of treatment with the DPP-4 inhibitor, sitagliptin, on gastrointestinal hormone responses to a standardized mixed meal and beta cell secretory capacity, measured as glucose and non-glucose induced insulin secretion during a hyperglycaemic clamp, in patients with type 2 diabetes.
AB - To examine the effects of 12 weeks of treatment with the DPP-4 inhibitor, sitagliptin, on gastrointestinal hormone responses to a standardized mixed meal and beta cell secretory capacity, measured as glucose and non-glucose induced insulin secretion during a hyperglycaemic clamp, in patients with type 2 diabetes.
KW - Adult
KW - Aged
KW - Diabetes Mellitus, Type 2
KW - Dipeptidyl-Peptidase IV Inhibitors
KW - Double-Blind Method
KW - Drug Administration Schedule
KW - Female
KW - Gastric Inhibitory Polypeptide
KW - Glucagon-Like Peptide 1
KW - Glucagon-Like Peptide 2
KW - Humans
KW - Hypoglycemic Agents
KW - Insulin
KW - Male
KW - Metformin
KW - Middle Aged
KW - Peptide YY
KW - Postprandial Period
KW - Pyrazines
KW - Triazoles
U2 - 10.1111/j.1463-1326.2009.01167.x
DO - 10.1111/j.1463-1326.2009.01167.x
M3 - Journal article
C2 - 20380653
VL - 12
SP - 323
EP - 333
JO - Diabetes, Obesity and Metabolism
JF - Diabetes, Obesity and Metabolism
SN - 1462-8902
IS - 4
ER -
